Video Experimental Relacionado
Updated: Jan 7, 2026
05:33
High-Throughput Cellular Profiling of Targeted Protein Degradation Compounds Using HiBiT CRISPR Cell Lines
Published on: November 9, 2020
10.9K
Degradación de proteínas dirigida: especies, enfermedades y utilización eficiente
Tian Yue1, Jian He1,2, Jun Hou3
1Department of Cardiology, Chengdu Institute of Cardiovascular Disease, The Third People's Hospital of Chengdu/Affiliated Hospital of Southwest Jiaotong University, Chengdu, Sichuan, 610031, China.
Journal of translational medicine
|December 26, 2025
Resumen
La degradación de proteínas dirigida (TPD) ofrece una nueva forma de tratar enfermedades eliminando proteínas dañinas. Esta revisión explora las estrategias de TPD y los sistemas de administración de fármacos para mejorar la eficacia terapéutica y la traslación clínica.
Área de la Ciencia:
- Bioquímica
- Biología Molecular
- Farmacología
Sus antecedentes:
- La degradación de proteínas dirigida (TPD) representa una estrategia terapéutica novedosa distinta de los inhibidores tradicionales.
- La TPD utiliza vías de aclaramiento endógenas como el sistema ubiquitina-proteasoma (UPS) y la vía lisosomal para eliminar proteínas diana.
- Las formulaciones actuales de TPD enfrentan desafíos que incluyen una biodisponibilidad deficiente y efectos fuera del objetivo, lo que limita la traslación clínica.
Objetivo del estudio:
- Proporcionar una visión general completa de las estrategias de TPD existentes y sus mecanismos.
- Resumir el progreso de la investigación de TPD en áreas clave de enfermedades como la oncología, los trastornos neurodegenerativos y las enfermedades inflamatorias/inmunológicas.
- Discutir el papel de los sistemas de administración de fármacos para superar las limitaciones de la TPD y mejorar los resultados terapéuticos.
Principales métodos:
- Revisión de diferentes estrategias de TPD y sus mecanismos de implementación.
- Resumen de la investigación actual sobre aplicaciones de TPD en los principales campos de enfermedades.
- Discusión sobre el potencial de los sistemas de administración de fármacos para la mejora de la formulación de TPD.
Principales resultados:
- Las estrategias de TPD incluyen varios enfoques para el etiquetado y la degradación de proteínas.
- La TPD muestra promesa en la terapia tumoral al dirigirse a proteínas clave como la quinasa de tirosina de Bruton (BTK), el receptor de andrógenos (AR) y el receptor de estrógeno (ER).
- Los sistemas de administración de fármacos tienen un potencial significativo para mejorar la biodisponibilidad y especificidad de la TPD.
Conclusiones:
- Esta revisión ofrece una comprensión detallada de los tipos de TPD, las aplicaciones en enfermedades y las estrategias de optimización.
- La aplicación eficaz de la TPD requiere abordar los desafíos de formulación.
- Se espera que los hallazgos guíen el desarrollo de formulaciones novedosas de TPD y aceleren la traslación clínica.
Videos de Conceptos Relacionados
02:58Regulated Protein Degradation
3.0K
3.0K
02:58Regulated Protein Degradation
8.7K
It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
8.7K
01:13The Proteasome
1.6K
Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
1.6K
02:18The Proteasome
10.0K
Eukaryotic cells can degrade proteins through several pathways. One of the most important amongst these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
10.0K
02:26Protein Networks
4.4K
An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
4.4K
01:18Amino Acid Catabolism
935
Microorganisms rely on proteins as an essential carbon and energy source, particularly in environments with limited polysaccharides or lipids. However, proteins are too large to cross the plasma membrane unaided, necessitating enzymatic degradation. Microbes secrete extracellular proteases and peptidases that hydrolyze proteins into peptides, which can then be transported across the membrane. Once inside the cell, intracellular proteases degrade these peptides into free amino acids, which...
935